Skip to main content

Peer Review reports

From: A 20-gene mutation signature predicts the efficacy of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer patients

Original Submission
8 Mar 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 May 2023 Reviewed Reviewer Report
24 May 2023 Reviewed Reviewer Report
2 Jun 2023 Author responded Author comments - Weijun Zhao
Resubmission - Version 3
2 Jun 2023 Submitted Manuscript version 3
Publishing
7 Jun 2023 Editorially accepted
22 Jun 2023 Article published 10.1186/s12890-023-02512-6

You can find further information about peer review here.

Back to article page